Beta-thalassemia: HBB (Full gene sequencing)

Alphabetical Test listing

Beta-thalassemia: HBB (Full gene sequencing)-994

  
Beta-thalassemia: HBB (Full gene sequencing)
  
994
  
LAB994
  
MSO
  
β-Thalassemia
  
  • Confirm a clinical diagnosis of β-thalassemia
  • Detect carriers
  • Help to establish a prognosis
  

This method does not reliably detect mosaic variants, large deletions, large duplications, inversions, or other rearrangements or deep intronic variants. It may be affected by allele-dropout, may not allow determination of the exact numbers of T/A or microsatellite repeats and it does not allow any conclusion as to whether two heterozygous variants are present on the same or on different chromosome copies.

  
EDTA whole blood
  
  
7 mL
  
3 mL
  

Immediately following collection, mix sample thoroughly by gentle inverting 8 - 10 times, to prevent clotting

  

Lavender (EDTA), 10mL

  
  • Test orders must include an attestation that the provider has the patient's Informed consent for genetic testing
  • Hospital clients submitting a request for this assay on an outpatient with Medicare should complete and submit a Molecular Medicare billing request form along with the sample.
    • Complete and submit the form to notify us of the need for Allina Health Laboratory to bill insurance for Molecular testing performed
    • All information requested is required in order for your request to be completed
  

Ambient

  
  • Container broken or leaking
  • Container not labeled or label not legible
  • Use of improper anticoagulant
  • Frozen specimen
  • Hemolysis
  • Quantity not sufficient for analysis
  • Improper container
  
LabCorp RTP (252823): R-NX
  
As needed, upon receipt
  
16 - 28 days
  

DNA sequencing

 

  

Normal equals reference sequence or variants that are known or predicted to be benign.

Abnormal equals all other variants.

  

This test covers all coding nucleotides of gene HBB, plus at least two and typically 20 flanking intronic nucleotides upstream and downstream of each coding exon, covering the conserved donor and acceptor splice sites, as well as typically 20 flanking nucleotides in the 5′ and 3′ UTR.

Test orders must include an attestation that the provider has the patient's informed consent for genetic testing.

  
Pre-authorization This test may require preauthorization from the insurance provider. Check the payer guidelines and, if needed, obtain the pre-authorization prior to sample collection.
  
81364
  
Yes
  
Result 21689-5
  

Medical necessity

Hospital clients submitting a request for this assay on an outpatient with Medicare should complete and submit a Molecular Medical billing request form along with the sample.

  • Complete and submit the form to notify us of the need for Allina Health Laboratory to bill insurance for Molecular testing performed
  • All information requested is required in order for your request to be completed

Molecular Medicare billing request

  
07/03/2019
  
01/04/2022
  
12/27/2023